Passilly-Degrace P - Search Results

1

Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.

Delmas D, Passilly-Degrace P, Jannin B, Cherkaoui Malki M, Latruffe N. Delmas D, et al. Int J Mol Med. 2002 Aug;10(2):193-9. Int J Mol Med. 2002. PMID: 12119558

2

Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent.

Latruffe N, Delmas D, Jannin B, Cherkaoui Malki M, Passilly-Degrace P, Berlot JP. Latruffe N, et al. Int J Mol Med. 2002 Dec;10(6):755-60. Int J Mol Med. 2002. PMID: 12430003

3

Ciprofibrate stimulates protein kinase C-dependent phosphorylation of an 85 kDa protein in rat Fao hepatic derived cells.

Passilly-Degrace P, Jannin B, Boscoboinik D, Motojima K, Latruffe N. Passilly-Degrace P, et al. Biochimie. 2000 Aug;82(8):749-53. doi: 10.1016/s0300-9084(00)01157-3. Biochimie. 2000. PMID: 11018292

4

Peroxisome-proliferator-activated receptors as physiological sensors of fatty acid metabolism: molecular regulation in peroxisomes.

Latruffe N, Cherkaoui Malki M, Nicolas-Frances V, Jannin B, Clemencet MC, Hansmannel F, Passilly-Degrace P, Berlot JP. Latruffe N, et al. Biochem Soc Trans. 2001 May;29(Pt 2):305-9. doi: 10.1042/0300-5127:0290305. Biochem Soc Trans. 2001. PMID: 11356172

5

Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.

Muller T, Demizieux L, Troy-Fioramonti S, Buch C, Leemput J, Belloir C, Pais de Barros JP, Jourdan T, Passilly-Degrace P, Fioramonti X, Le Bon AM, Vergès B, Robert JM, Degrace P. Muller T, et al. Among authors: passilly degrace p. Int J Mol Sci. 2022 Mar 8;23(6):2923. doi: 10.3390/ijms23062923. Int J Mol Sci. 2022. PMID: 35328343 Free PMC article.

6

Xaliproden (SR57746A) induces 5-HT1A receptor-mediated MAP kinase activation in PC12 cells.

Appert-Collin A, Duong FH, Passilly DeGrace P, Bennasroune A, Poindron P, Warter JM, Gies JP. Appert-Collin A, et al. Int J Immunopathol Pharmacol. 2005 Apr-Jun;18(2):233-44. doi: 10.1177/039463200501800206. Int J Immunopathol Pharmacol. 2005. PMID: 15888246 Free article.

7

MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of xaliproden.

Appert-Collin A, Duong FH, Passilly Degrace P, Warter JM, Poindron P, Gies JP. Appert-Collin A, et al. Int J Immunopathol Pharmacol. 2005 Jan-Mar;18(1):21-31. doi: 10.1177/039463200501800104. Int J Immunopathol Pharmacol. 2005. PMID: 15698508 Free article.

8

Do we taste fat?

Laugerette F, Gaillard D, Passilly-Degrace P, Niot I, Besnard P. Laugerette F, et al. Biochimie. 2007 Feb;89(2):265-9. doi: 10.1016/j.biochi.2006.10.011. Epub 2006 Nov 10. Biochimie. 2007. PMID: 17126471 Review.

9

Is the taste of fat regulated?

Passilly-Degrace P, Chevrot M, Bernard A, Ancel D, Martin C, Besnard P. Passilly-Degrace P, et al. Biochimie. 2014 Jan;96:3-7. doi: 10.1016/j.biochi.2013.07.029. Epub 2013 Aug 9. Biochimie. 2014. PMID: 23933093 Review.

10

A chronic LPS-induced low-grade inflammation fails to reproduce in lean mice the impairment of preference for oily solution found in diet-induced obese mice.

Bernard A, Ancel D, Passilly-Degrace P, Landrier JF, Lagrost L, Besnard P. Bernard A, et al. Among authors: passilly degrace p. Biochimie. 2019 Apr;159:112-121. doi: 10.1016/j.biochi.2018.08.004. Epub 2018 Aug 10. Biochimie. 2019. PMID: 30102932 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page